Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05917_nanopub.RARCR5CHLvh5XN1fKZCbA0_KGtV_fFIfWDmXicGXBl-LE#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB05917 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05917 label "EP-1572 [drugbank:DB05917]" assertion.
- drugbank:DB05917 seeAlso DB05917 assertion.
- drugbank:DB05917 description "AEZS-130 (EP-1572) is novel peptidomimetic growth hormone secretagogues (GHS) which represent a new class of pharmacological agents which have the potential to be used in numerous clinical applications. They include treatment for growth retardation in children and cachexia associated with chronic disease such as AIDS and cancer." assertion.
- drugbank:DB05917 identifier "drugbank:DB05917" assertion.
- drugbank:DB05917 title "EP-1572" assertion.
- drugbank:DB05917 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05917 drugbank_vocabulary:drugbank-id "DB05917" assertion.
- drugbank:DB05917 bio2rdf_vocabulary:x-identifiers.org DB05917 assertion.
- drugbank:DB05917 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05917" assertion.
- drugbank:DB05917 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05917 bio2rdf_vocabulary:identifier "DB05917" assertion.
- drugbank:DB05917 drugbank_vocabulary:x-wikipedia wikipedia:Growth_hormone_secretagogue_receptor assertion.